I'll further the original question. If you want to cited the aforementioned or not that's fine.
Out of curiosity. How did you undergo accessing your clients actual loss in LBM with the additional use of liothyronine? Was it through urinary analysis, caliper, DEXA, BIA, CT or MRI. Or by visualization and scale weight?
If none of the standardized methods to determine fat percentage was utilized. How would we/you know if "said client(s)" may still had minimal amounts of intramuscular fat that could appear as lean muscle tissue visually. There's methods to determine this. Very lean individuals with low body fat can have intramuscular fat. To the naked eye, this can be deceiving.
If, a wild if that would be the case of hiden intramuscular fat with the reduction of BW and visually- caliperd smaller muscle bellies. How would one know if it was actually lipolysis, proteolytic or a combination of both.
The queries remains; was liothyronine to blame on reving-up UPS-proteolysis or facilitating that extra lipolysis.